BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SETD2, ENSG00000181555, 29072 AND Diagnosis
8 results:

  • 1. Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms.
    Vormittag-Nocito E; Mannan R; Wang X; Chinnaiyan A; Zhang Y; Zelenka-Wang S; Cao X; Morgan TM; Hafez K; Vaishampayan U; Abdulfatah E; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Hum Pathol; 2022 Dec; 130():95-109. PubMed ID: 36511267
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
    Sahu DK; Singh N; Das M; Rawat J; Gupta DK
    Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
    He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
    BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
    Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus.
    Wang XM; Lu Y; Song YM; Dong J; Li RY; Wang GL; Wang X; Zhang SD; Dong ZH; Lu M; Wang SY; Ge LY; Luo GD; Ma RZ; George Rozen S; Bai F; Wu D; Ma LL
    Nat Commun; 2020 Feb; 11(1):739. PubMed ID: 32029730
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.
    Manley BJ; Reznik E; Ghanaat M; Kashan M; Becerra MF; Casuscelli J; Tennenbaum D; Redzematovic A; Carlo MI; Sato Y; Arcila M; Voss MH; Feldman DR; Motzer RJ; Russo P; Coleman J; Hsieh JJ; Hakimi AA
    Urol Oncol; 2019 Jan; 37(1):12-17. PubMed ID: 29132830
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic characterisation of two cancers of unknown primary cases supports a kidney cancer origin.
    Wei EY; Chen YB; Hsieh JJ
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26494726
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.